Notes from iRobot (IRBT) Analyst Day - Needham & Company
Get Alerts IRBT Hot Sheet
Rating Summary:
4 Buy, 10 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 14
Join SI Premium – FREE
Needham & Company analyst, James Ricchiuti, attended the iRobot Corporation (NASDAQ: IRBT) analyst day. The key takeaway was the recognition that the main driver to its business for the foreseeable future is likely to be its home robot business, including the next-gen Roomba 980 with upside opportunities from wet floor care and robotic lawn mowers. Notes follow:
Having seen strong results from TV advertising this year, IRBT plans to step up ad spending in Q4. The TV campaign in the 3 weeks leading up to Mother's Day this year produced a 101% increase in retail unit off-take over the same period a year earlier. IRBT is clearly upping the ante for Roomba, having seen strong results from TV advertising campaigns this year and plans additional TV-ad spending in Q4. Mgmt sees an immediate addressable market opportunity for Roomba that is ~4x the current robotic vacuum cleaner installed base in the U.S.
IRBT appears likely to move forward with a robotic lawn mower, initially we believe targeting an existing market for robotic lawn mowers in Europe, a market currently estimated at $200M.
Management did not spend much time on the Defense & Security (D&S) business, which is currently only 4% revenue. However, IRBT is pursuing two large programs of record (CRS-1 and CLARK).
Ricchiuti believes there is significant runway for growth with Roomba, and he maintains his Buy rating and $38 PT.
For an analyst ratings summary and ratings history on iRobot Corporation click here. For more ratings news on iRobot Corporation click here.
Shares of iRobot Corporation closed at $31.59 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- IROBOT CORPORATION (NASDAQ: IRBT) DEADLINE ALERT: Bernstein Liebhard LLP Reminds iRobot Corporation Investors of Upcoming Deadline
- Day One Biopharmaceuticals (DAWN) PT Raised to $33 at Needham
- Prudential Financial (PRU) PT Raised to $116 at Evercore ISI
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
Needham & Company, S1Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!